GERM Amplify Treatments, Testing...


$ -0.06 (-0.29 %)    

QQQ $ 635.69 $ 0.09 (0.01 %)
DIA $ 478.79 $ 0.13 (0.03 %)
SPY $ 688.96 $ 0.24 (0.03 %)
TLT $ 91.83 $ -0.05 (-0.05 %)
GLD $ 368.92 $ -0.77 (-0.21 %)
$ 19.1577
-- x --
-- x --
-- - --
$ 16.24 - $ 20.10
4,828
na
na
$ 0.78
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mpox-variant-sparks-global-concern-as-europe-china-ramp-up-screening

Increased screening for deadly new version of mpox is seen in Europe and China. More imported cases are expected. New vaccines ...

 fda-set-to-approve-covid-19-vaccines-as-soon-as-this-week-stocks-etfs-to-watch

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer ou...

 moderna-stock-moves-after-q1-print-technical-levels-for-the-covid-19-vaccine-play

Moderna Inc. (NASDAQ: MRNA) shares gapped down Thursday and have since gained back some ground.

 first-vaccine-etf-should-see-halcyon-days-ahead

There was big news on the coronavirus vaccine front Monday when Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX)

 virs-makes-pandemic-vaccine-etf-competition-more-interesting

It was just a week ago that the first exchange-traded fund dedicated to vaccine developers, plenty engaged in the fight against...

 moderna-other-vaccine-developers-lead-the-way-in-new-germ-etf

Vaccines are all the rage these days, both in the medical and investment fields. Now, there's an exchange-traded fund for t...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION